CEO Jean Jacques Bienaime sold $1.7M of BioMarin Pharmaceutical Inc.

Sold$1,671,131

$89.13Price

18,750Shares

−4%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Wed, May 16. Filed Thu, May 17, 8:03 PM ET, after the close. Not investment advice.